PGY2 Oncology Pharmacy Residency Program

 

Residency Program Director
Amber B. Clemmons, Pharm.D., BCOP
aclemmons@augusta.edu

Applications and Inquiries:   (Accepting inquiries for 2020-2021 residency year)
                                             

Oncology Preceptors
Joshua Wyche, Pharm.D., MBA; Arpita Shah Gandhi, Pharm.D., BCOP; Amber Clemmons, Pharm.D., BCOP; Katie Saunders, Pharm.D.; Cara Iacobellis, Pharm.D.. 
(not pictured:  Carolyn Braithwaite, Pharm.D., Marjorie Shaw Phillips, M.S., R.Ph., CIP; LeeAnn Thompson Lee, Pharm.D., BCPPS.; Andrea Clarke, Pharm.D.)

Past Residents

Year Resident Position After Graduation (current)

2011-2012

Katerina (Katsanevas) Butler, PharmD, BCOP Clinical Pharmacy Specialist Hematology/Oncology, AU Medical Center (now at VA in Salt Lake City UT)

2012-2013

Stephen Clark, PharmD, BCOP Clinical Pharmacy Specialist Hematology/Oncology, AU Medical Center (now inpatient at UNC in NC)

2012-2013

Alison (Steinbach) Tokarchic, PharmD Clinical Pharmacy Specialist Hematology/Oncology (outpatient) at Alleghany Health Network in PA

2013-2014

Megan Hartranft, PharmD, BCPS, BCOP Clinical Assistant Professor at Rosalind Franklin University & Ambulatory Care Hematology/Oncology Clinical Pharmacy Specialist at Rush University Medical Center in Chicago, IL. (now MLS with PHARMA)

2014-2015

Sarah (Evans) Hoffman, PharmD, BCOP Clinical Pharmacy Specialist Inpatient/Outpatient Medical Oncology at the Ohio State University Comprehensive Cancer Center in OH

2015-2016

Julianne (Orr) Darling, PharmD, BCOP Oncology Clinical Pharmacist at the Indiana University Health in IN

2016-2017

Benjamin Andrick, PharmD, BCOP Hematology/Oncology Clinical Pharmacist and Clinical Investigator at Geisinger Health in PA

2017-2018

Morgan (Gwynn) Stanley, YeaPharmD, BCOP Oncology Clinical Pharmacist at the University of North Carolina in Chapel Hill, NC
2018-2019 Kori Daniels, PharmD BMT Clinical Pharmacy Specialist at Methodist University Hospital in Memphis, TN

 

Residency Purpose

PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both to the provision of patient care or other advance practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialize positions, along with board certification, if available.

This PGY2 residency program provides the resident with advanced clinical training in hematology/oncology and supportive care pharmacotherapy, as well as numerous opportunities for teaching and scholarship. Upon completion of this residency, the pharmacist will be a competent clinical pharmacy practitioner who engages in multidisciplinary collaboration, demonstrates advanced critical thinking skills, and promotes patient advocacy. Graduates of this program will be adequately prepared to
enter oncology pharmacy practice as a clinical specialist and/or academician.